SPON2 and neoplasm: Significantly, DDP treatment caused a significant reduction in Spon2 levels in both A549/DDP cells and tumor tissues from A549/DDP xenograft mice, compared to the A549/DDP group; meanwhile, IGF2BP2 deficiency further reduced Spon2 expression (Figs. 8C and D and 9A).